Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07463053) titled 'Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers' on March 2.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Jemincare

Condition: ADPKD (Autosomal Dominant Polycystic Kidney Disease)

Intervention: Drug: [14C]JMKX003142 Drug: JMKX003142 tablets

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: March 18, 2026

Target Sample Size: 8

To know more, visit https://clinicaltrials.gov/study/NCT07463053

Published ...